|
TO: |
Board of Trustees |
|
THROUGH: |
Mary DeLoretto, Interim Executive Director |
|
FROM: |
Nichol Bourdeaux, Chief Planning and Engagement Officer |
|
PRESENTER(S): |
Jaron Robertson, Director Innovative Mobility Solutions |
|
|
|
TITLE:

title
UTA On Demand: South Salt Lake County Service Update
end

AGENDA ITEM TYPE:
Discussion

RECOMMENDATION:
Informational report for discussion

BACKGROUND:
The South Salt Lake County Microtransit Service (UTA On Demand) began as a pilot in November 2019. The pilot experienced early adoption and success prior to the COVID-19 pandemic meeting most goals and objectives. UTA continued and extended the pilot throughout the COVID-19 pandemic and was able to demonstrate the nimbleness and adaptability of microtransit by continuing to provide high-quality transit service, maintaining a good customer experience, and lowering operating expenses. As part of the August 2021 change day and UTA’s Five-Year Service Plan, UTA made the pilot a permanent service and discontinued five flex route services within the area.
As part of the August 2021 change day, the service continues to operate in the cities of Bluffdale, Draper, Herriman, Riverton, and sections of Sandy, and South Jordan. The service area was expanded from 65 to 71 square miles. Operating hours were expanded from Monday - Friday, 6:00 am to 9:00 pm to Monday - Friday, 4:00 am to 12:15 am. Saturday service was also added and operates from 6:00 am to 1:15 am. UTA and Via launched a new UTA branded app, and the service began providing paratransit to microtransit connections.

DISCUSSION:
Staff will provide an update to the UTA Board of Trustees regarding service performance since the August 2021 change day. Discussion topics will include the following:
• Overview of service changes
• Overview of service performance including ridership, customer experience, travel patterns, and paratransit connections
• Successes and challenges with the service
• Marketing and communications update

ALTERNATIVES:
N/A

FISCAL IMPACT:
N/A

ATTACHMENTS:
None